Evaluation of99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 54, Issue 4, 2010, Pages 442-450

  Brouwer, C P J M ^a,b   Gemmel, F F A Y ^c   Welling, M M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c KCL Medical Center   (Netherlands)

Author keywords

Drug resistance; Endocarditis, bacterial; Technetium 99m ubiquicidin(29 41)

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TECHNETIUM 99M; UBIQUICIDIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PEPTIDE FRAGMENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M UBIQUICIDIN(29 41); TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ENDOCARDITIS; EX VIVO STUDY; EXPERIMENTAL RAT; EXPERIMENTAL STUDY; FEMALE; IN VIVO STUDY; ISOTOPE LABELING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RADIODIAGNOSIS; RAT; SCINTIGRAPHY; ANIMAL; DISEASE MODEL; EVALUATION; HUMAN; SCINTISCANNING; STAPHYLOCOCCUS INFECTION; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS;

EID: 78650675906     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Thompson J, Meddens MJ, Thorig L, van Furth R. The role of bacterial adherence in the pathogenesis of infective endocarditis. Infection 1982;10:196-8.
2. Meddens MJ, Thompson J, Eulderink F, Bauer WC, Mattie H, van Fürth R. Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect Immun 1982;36:325-32.
3. Meddens MJ, Thompson J, Bauer WC, Hermans J, van Fürth R. Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis. Infect Immun 1983;41:145-53.
4. Scheld WM, Sande MA. Endocarditis and intravascular infections. In: Mandel GLM, Douglas RG BJ, editors. Principles and practices of infectious diseases. New York: Wiley, 1985:504-30.
5. Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 1986;8:364-73.
6. Francis J, Newsom SW. Treatment of streptococcal and staphylococcal endocarditis. J Antimicrob Chemother 1986;18:554-6.
7. Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphylococcus aureus septicemia. To seek is to find. Infection 2000;28:132-6.
8. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-30.
9. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-49.
10. Beynon RP, Bahl VK, Prendergast BD. Infective endocarditis. BMJ 2006;333:334-9.
11. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. AmJ Med 1994;96:200-9.
12. Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective endocarditis. Cardiol Clin 2003;21:185-95.
13. Lang S. Getting to the heart of the problem: serological and molecular techniques in the diagnosis of infective endocarditis. Future Microbiol 2008;3:341-9.
14. Nibbering PH, Welling MM, van den Broek PJ, van Wyngaarden KE, Pauwels EK, Calame W Radiolabelled antimicrobial peptides for imaging of infections: a review. Nucl Med Commun 1998;19:1117-21.
15. Ivancevic V, Munz DL. Nuclear medicine imaging of endocarditis. QJ Nucl Med 1999;43:93-9.
16. Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A et al. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun 2006;27:213-22.
17. Munz DL, Morguet AJ, Sandrock D, Heim A, Sold G, Figulla HR et al. Radioimmunoimaging of subacute infective endocarditis using a technetium-99m monoclonal granulocyte-specific antibody. Eur J Nucl Med 1991;18:977-80.
18. Morguet AJ, Munz DL, Ivancevic V, Werner GS, Sandrock D, Bokemeier M et al. Immunoscintigraphy using technetium-99mlabeled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Coll Cardiol 1994;23:1171-8.
19. Gratz S, Raddatz D, Hagenah G, Behr T, Behe M, Becker W. 99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis. Int J Cardiol 2000;75:75-84.
20. Ellemann A, Rubow S, Erlank P, Reuter H. Is there a role for 99mTc-HMPAO leucocyte scintigraphy in infective endocarditis? Cardiovasc J S Afr 2003;14:199-203.
21. Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Caíame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med 1999;40:2073-80.
22. Welling MM, Paulusma-Annema A, Baiter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. EurJ Nucl Med 2000;27:292-301.
23. Brouwer CP, Bogaards SJ, Wulferink M, Velders MP, Welling MM. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multidrug resistant) Staphylococcus aureus in mice. Peptides 2006;27:2585-91.
24. Welling MM, Brouwer CP, van't Hof W, Veerman EC, Amerongen AV. Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo. Antimicrob Agents Chemother 2007;51:3416-9.
25. Brouwer CP, Wulferink M, Welling MM. The pharmacology of radiolabeled cationic antimicrobial peptides. J Pharm Sci 2008;97:1633-51.
26. Welling MM, Korsak A, Gorska B, Oliver P, Mikolajczak R, Baiter HS et al. Kit with technetium-99m labelled antimicrobial peptide UBI 29-41 for specific infection detection. Journal of Labelled Compounds and Radiopharmaceuticals 2005;48:683-91.
27. Ferro-Flores G, De Murphy CA, Palomares-Rodriguez P, Melendez-Alafort L, Pedraza-Lopez M. Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29-41. Journal of Radioanalytical and Nuclear Chemistry 2005;266:307-11.
28. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, Arteaga dM, Herrera-Rodriguez R, Mitsoura E et al. Biokinetics of (99m)Tc-UBI 29-41 in humans. Nucl Med Biol 2004;31:373-9.
29. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infectionimaging agent: clinical trial. J Nucl Med 2005;46:567-73.
30. Cairo AH, Santana CC, Cuellar JFB, Capote AP, Perez MAC, Valdes MP. Image of sepsis associated with histiocytosis X. Revista Espanola de Medicina Nuclear 2008;27:205-6.
31. Pauwels EKJ, Welling MM, Balter HS, Lupetti A, Nibbering P. Technetium-99m labeled cationic antimicrobial peptides for infection detection and treatment monitoring. Drugs of the Future 2003;28:975-81.
32. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004;45:321-6.
33. Santoro J, Levison ME. Rat model of experimental endocarditis. Infect Immun 1978;19:915-8.
34. de Koster HS, Amons R, Benckhuijsen WE, Feijlbrief M, Schellekens GA, Drijfhout JW. The use of dedicated peptide libraries permits the discovery of high affinity binding peptides. J Immunol Methods 1995;187:179-88.
35. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004;45:321-6.
36. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92:879-85.
37. Welling MM, Mongera S, Lupetti A, Balter HS, Bonetto V, Mazzi U et al. Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections. Nud Med Biol 2002;29:413-22.
38. Lupetti A, Welling MM, Mazzi U, Nibbering PH, Pauwels EK. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging 2002;29:674-9.
39. Sachdev M, Peterson GE, Jollis JG. Imaging techniques for diagnosis of infective endocarditis. Cardiol Clin 2003;21:185-95.
40. Morguet AJ, Munz DL, Kreuzer H, Emrich D. Scintigraphic detection of inflammatory heart disease. EurJ Nucl Med 1994;21:666-74.
41. Buscombe JR. The future of infection imaging. QJ Nucl Med Mol Imaging 2006;50:99-103.
42. Benitez A, Roca M, Martin-Comin J. Labeling of antibiotics for infection diagnosis. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006;50:147-52.
43. Brouwer CP, Sarda-Mantel L, Meulemans A, Le Guludec D, Welling MM. The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging. Mini Rev Med Chem 2008;8:1039-52.
44. Rouzet F, Hernandez MD, Hervatin F, Sarda-Mantel L, Lefort A, Duval X et al. Technetium 99m-labeled annexin v scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation 2008;117:781-9.